Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Therapeutic apheresis in malignancy.

S Nand

    Therapeutic Apheresis : Official Journal of the International Society for Apheresis and the Japanese Society for Apheresis
    |February 1, 1997
    PubMed
    Summary

    Plasmapheresis (PP) and staphylococcal protein A immunoadsorption (SPI) offer temporary immune responses in cancer treatment with unproven clinical utility. Extracorporeal photochemotherapy (EP) shows promise for cutaneous T-cell lymphomas.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Sensitizing acute myeloid leukemia cells to induced differentiation by inhibiting the RIP1/RIP3 pathway.

    Leukemia·2016
    Same author

    Primary talectomy for severe fracture-dislocation of the talus with a 15-year followup: case report.

    Foot & ankle international·2007
    Same author

    Lymphoproliferative disorders in chronic hepatitis C.

    Journal of viral hepatitis·2004
    Same author

    Herpes zoster during treatment with arsenic trioxide.

    Annals of hematology·2004
    Same author

    Superior sagittal sinus thrombosis in a child with Down syndrome.

    Journal of paediatrics and child health·2003
    Same author

    Hepatitis C virus infection and lymphoproliferative disorders.

    Digestive diseases and sciences·2000

    Area of Science:

    • Immunology
    • Oncology
    • Medical Technology

    Background:

    • Plasmapheresis (PP), staphylococcal protein A immunoadsorption (SPI), and extracorporeal photochemotherapy (EP) have been used in cancer therapy for two decades.
    • These extracorporeal immunomodulatory treatments aim to influence the immune system for therapeutic benefit in cancer patients.
    • PP and SPI modulate immune complexes and cellular responses, while EP targets lymphoma cells and enhances anti-tumor immunity.

    Discussion:

    • PP and SPI demonstrate transient immune enhancements, including increased T4/T8 ratios and natural killer cell activity, but lack sustained clinical efficacy.
    • While PP may offer short-lived remissions in some cancers, its addition to chemotherapy has shown potential survival benefits in multiple myeloma.
    • SPI yields comparable results to PP, suggesting limited independent clinical value for these methods in broad cancer treatment.

    Key Insights:

    • Extracorporeal photochemotherapy (EP) has shown notable efficacy in cutaneous T-cell lymphomas, with 25% complete and 50% partial response rates.
    • EP enhances the lysis of circulating lymphoma cells via CD8+ cytotoxic T cells and boosts host monocyte production of tumor necrosis factor.
    • PP and SPI induce temporary immune modulation but have not established proven clinical utility for widespread cancer treatment.

    Outlook:

    • Further research is needed to elucidate the precise mechanisms and long-term benefits of EP in T-cell lymphomas.
    • Investigating combination therapies involving EP could potentially improve outcomes for specific hematological malignancies.
    • The limited clinical utility of PP and SPI suggests a need for alternative or refined immunomodulatory strategies in oncology.

    Related Experiment Videos